CannTrust Holdings Cuts 20% of Workforce

Canntrust Holdings (TSX: TRST) (NYSE: CTST) announced this evening that it will be reducing its workforce significantly as a result of its ongoing troubles at both its Pelham, Ontario, and Vaughan, Ontario facilities.

The move impacts 180 employees at the company, or roughly 20% of its entire workforce. The move is being taken by management as a result of its ongoing discussions with that of Health Canada with respect to the licensing status at both of its facilities.

“We have made the extremely difficult decision to restructure our workforce to reflect the current requirements of our business. These changes also position the Company to better serve our patients and customers with high quality, innovative products in the future.”

“Over the past two months, we have moved swiftly to assess and address the Health Canada report indicating areas of non-compliance in our operations, as well as the findings of the Special Committee’s independent investigation. We remain fully committed to building the organization we need for future success and rebuilding the trust of all of our stakeholders.”

Robert Marcovitch, CannTrust interim Chief Executive Officer

The affected employees, which largely consists of cultivation and customer service roles, is anticipated to reduce annual wage spend by $9 million. Severance costs alone are anticipated to come in at roughly $2 million.

CannTrust initially stopped the sale of all product on a voluntary basis back on July 11, after reporting the previous week that it was found to be growing cannabis illegally in rooms that were not licensed by Health Canada. The producer had duped regulatory officials through the installation of fake poly walls which were used to hide the illegal plants being grown. The lack of sales is believed to equate to roughly $187,000 in lost sales per day, in addition to close to $70 million of inventory currently placed in an “on hold” status by both Health Canada and Canntrust until further notice.

This latest news comes on the heels of the anticipated drop from the S&P/TSX Composite index for the firm, as per a recent Globe and Mail report.

CannTrust Holdings closed at $1.76 today on the New York Stock Exchange.


Information for this briefing was found via Sedar and CannTrust Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

The Financial Impact of CannTrust Holdings Illegal Actions

CannTrust Holdings (TSX: TRST) (NYSE: CTST) has stopped selling product to patients. In an after...

Friday, July 12, 2019, 10:47:08 AM

CannTrust Nailed for Selling Unlicensed Product

This morning CannTrust announced a bombshell for the cannabis industry. The Company put out in...

Monday, July 8, 2019, 08:14:59 AM

Canntrust Confirms Delisting From NYSE, TSX

It seems that it’s all over for Canntrust Holdings (TSX: TRST) (NYSE: CTST) shareholders. The...

Friday, April 10, 2020, 10:04:08 AM

Emerald Health Signs Supply Agreement with Stenocare

Emerald Health Therapeutics (TSXV: EMH) is Stenocare’s new supplier of choice following the fallout earlier...

Thursday, November 7, 2019, 09:34:55 AM

Canntrust Obtains Creditor Protection, Anticipates TSX, NYSE Delisting

Canntrust Holdings (TSX: TRST) (NYSE: CTST) this morning announced that it has entered into creditor...

Tuesday, March 31, 2020, 11:05:39 AM